Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Gains from Investment Securities (2021 - 2025)

Stoke Therapeutics has reported Gains from Investment Securities over the past 5 years, most recently at $12.0 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 328.65% year-over-year to $12.0 million; the TTM value through Sep 2025 reached $809300.0, up 10.97%, while the annual FY2025 figure was $4.3 million, 54.04% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $12.0 million at Stoke Therapeutics, up from $809300.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $12.0 million in Q4 2025 and troughed at $79400.0 in Q3 2022.
  • A 5-year average of $2.1 million and a median of $998356.0 in 2024 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: surged 657.01% in 2024 and later plummeted 54.61% in 2025.
  • Year by year, Gains from Investment Securities stood at $5.4 million in 2021, then tumbled by 36.35% to $3.5 million in 2022, then crashed by 97.22% to $96340.0 in 2023, then skyrocketed by 2803.89% to $2.8 million in 2024, then surged by 328.65% to $12.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for STOK at $12.0 million in Q4 2025, $809300.0 in Q3 2025, and $407482.0 in Q2 2025.